Towards Healthcare

Implantable Medical Devices Market Advancements and Forecast (2025 - 2034)

According to forecasts, the global implantable medical devices market will grow from USD 97.17 billion in 2024 to USD 176.33 billion by 2034, with an expected CAGR of 6.14%. In 2024, North America led the implantable medical devices market with 44% share. Cardiovascular implants dominated, while dental implants are expected to grow the fastest. Metallic biomaterials led, but natural materials are projected to grow rapidly. Hospitals were the largest end-user, with outpatient facilities growing fast.

Insight Code: 5517 Format: PDF / PPT / Excel
Last Updated: 02 April 2025 Category: Medical Devices

Principal Consultant

Shivani Zoting

Reviewed By

Aditi Shivarkar

The global implantable medical devices market size is calculated at USD 97.17 billion in 2024, grew to USD 103.14 billion in 2025, and is projected to reach around USD 176.33 billion by 2034. The market is expanding at a CAGR of 6.14% between 2025 and 2034. The rising prevalence of chronic disorders, increasing number of surgeries, and technological advancements drive the market.

Implantable Medical Devices Market Size 2023 - 2034

Key Takeaways

  • North America dominated the global market share by 44% in 2024.
  • Asia-Pacific is projected to host a significantly growing implantable medical devices market in the coming years.
  • By product, the cardiovascular implants segment held a dominant presence in the market in 2024.
  • By product, the dental implants segment is expected to grow at the fastest rate in the market during the forecast period.
  • By biomaterial, the metallic segment held the largest share of the market in 2024.
  • By biomaterial, the natural segment is anticipated to grow with the highest CAGR in the market during the studied years.
  • By end-use, the hospitals segment led the global market in 2024.
  • By end-use, the outpatient facilities segment is projected to expand rapidly in the market in the coming years.

Implantable Medical Devices Market: Bio-Tech Synergy

Implantable medical devices are tools that are either placed inside the body or on its surface. They are either placed for a temporary or permanent purpose, depending on the patient’s conditions. Some of the most common examples of implantable devices include artificial joints, breast implants, cochlear implants, pacemakers, and intraocular lenses. These devices are used for a wide range of purposes, including prosthetics, medication delivery, monitoring body functions, and providing support to organs and tissues.

The rising prevalence of chronic disorders increases the need for implants to maintain body functions. The increasing number of surgeries globally boosts the market. The growing research and development activities lead to the development of novel implants. Technological advancements such as AI and 3D printing augment market growth. Favorable regulatory frameworks and increasing investments from government and private organizations favor the development of novel implants.

Novel Medical Devices, 2023

  • In February 2025, Silq Technologies Corporation announced a collaboration with NuSil Technology, LLC, to facilitate the utilization of Silq’s zwitterionic surface treatment technology on implantable medical devices produced with NuSil’s silicone products. The technology will be used to resolve complications such as infections, premature device failure, and surgical removal and replacement.
  • In February 2025, StairMed announced the closing of its Series B funding round, raising $48 million, marking the largest investment in China’s implantable brain-machine interface industry. The funding would accelerate clinical trials, advance research and development of next-generation technologies, and build a medical-grade microelectromechanical production facility.
  • In July 2024, Neuspera Medical, Inc. announced that it raised $23 million in a Series D funding round. The funding was raised to facilitate the FDA pre-market approval of the Neuspera system, a minimally invasive and ultra-miniaturized implant for providing relief from urinary urge incontinence (UUI).

Impact of AI on the Implantable Medical Devices Market

Integrating artificial intelligence (AI) into implantable medical devices leads to the development of “smart implants”. Smart implants contain sensors that provide real-time monitoring data of a patient’s conditions. They also enable healthcare professionals to monitor the health and function of the implant. AI and machine learning (ML) algorithms enhance diagnostic capabilities and facilitate personalized interventions. AI and ML allow researchers to adapt designs to specific patient needs and complex medical requirements and accelerate the development process. Integrating AI in implantable devices exhibits strengths in longevity. AI can enable researchers to develop devices with longer battery life, simplify programming, and enable remote monitoring. AI and ML can also predict rejection rates, allowing healthcare professionals to overcome biocompatibility issues.

Market Dynamics

Driver

Minimally Invasive Surgeries

The major growth factor of the implantable medical devices market is the growing demand for minimally invasive surgeries. Minimally invasive surgeries result in smaller incisions, resulting in faster recovery and fewer complications. It reduces trauma, pain, complications, scarring, and recovery time for patients. It also results in a reduced risk of infection and shorter hospital stay. The increasing number of minimally invasive surgeries potentiates the demand for implantable medical devices. These surgeries necessitate the use of implantable devices. Some common examples include laparoscopes, endoscopes, and robotic surgery systems. These devices are used to view the organs and tissues inside the body during a surgical procedure. It is estimated that 15.2 million laparoscopic procedures, such as cholecystectomy, nephrectomy, and bariatric surgery, were performed globally in 2023. Numerous researchers are developing implantable devices that can be inserted through minimally invasive surgeries, enhancing treatment accessibility.

Restraint

Biocompatibility Issues

The major challenge of the market is the biocompatibility issue of implantable medical devices. The body’s natural foreign response restricts implantable devices, leading to inflammation, scarring, and potential device failure. This presents a significant risk to the patient, hinders market growth.

Opportunity

3D and 4D Printing

The future of the implantable medical devices market is promising, driven by the advent of 3D and 4D printing technologies. 3D printing is an advanced technology to manufacture three-dimensional objects from digital files. 4D printing refers to manufacturing objects that change shape or properties over time. These technologies offer superior benefits over conventional manufacturing techniques. They lead to the development of personalized implants, depending on the patient’s needs. Implants produced through 3D and 4D printing can act as specific carriers for accurate drug release and delivery and other necessary purposes, enhancing therapeutic effects and reducing side effects. The future of biomedical science, patient-centered care, and medical devices could be completely transformed in the future by further advancements in 3D and 4D printing technologies.

Segmental Insights

Cardiovascular Implants Segment Dominated

By product, the cardiovascular implants segment held a dominant presence in the implantable medical devices market in 2024. The rising prevalence of cardiovascular disorders and growing research and development activities boost the segment’s growth. It is estimated that a person dies of cardiovascular disorders every 33 seconds in the U.S. Cardiovascular implants include pacemakers, implantable cardioverter defibrillators, biventricular pacemakers, artificial heart valves, and stents. Advances in microelectronics lead to the development of smart cardiovascular implants, propelling the segment’s growth.

Dental Implants Segment: Fastest Growing

By product, the dental implants segment is expected to grow at the fastest rate in the market during the forecast period. The rising incidences of dental disorders and growing awareness for oral health augment the segment’s growth. In 2023, approximately 1.1 million dental implants were placed in California. Technological advancements in nanotechnology and 3D printing have revolutionized the dental implants industry. Dental implants can also enhance a person’s aesthetic appearance. Thus, the burgeoning medical device and biomedical sectors facilitate the segment’s growth.

Metallic Segment Held the Largest Share

By biomaterial, the metallic segment held the largest share of the implantable medical devices market in 2024. A metallic implant is a type of medical device that is made from metals such as stainless steel, cobalt-chromium, or titanium. Metallic implants offer high strength, high fracture toughness, and hardness. Ongoing research efforts are made to enhance the corrosion resistance of metallic implants and improve their biocompatibility. Metallic implants are used in a wide range of applications, from cardiovascular to orthopedic. They are used to produce stents, prosthetics, and drug delivery systems.

Natural Segment: Fastest Growing

By biomaterial, the natural segment is anticipated to grow with the highest CAGR in the market during the studied years. Natural implants are commonly made of hyaluronic acid, chitosan, collagen, gelatin, silk, and cellulose. The growing demand for stem cells and tissues potentiates the development of natural segments. Natural implants offer more biocompatibility than metallic implants. The rising need for biodegradable implants also promotes the segment’s growth. Biodegradable implants eliminate the need for an extra surgical procedure to remove the implantable device, reducing healthcare costs and improving patient compliance.

Hospitals Segment Led in 2024

By end-use, the hospitals segment led the global implantable medical devices market in 2024. The increasing number of hospitalizations and surgeries due to the rising prevalence of acute and chronic disorders fuels the segment’s growth. Hospitals have favorable infrastructure and suitable capital investments to adopt advanced implantable devices. Favorable reimbursement policies also contribute to the segment’s growth. Hospitals stay up-to-date with the latest technologies and newly launched implantable devices, offering advanced treatment and care to patients.

Outpatient Facilities Segment: Fastest Growing

By end-use, the outpatient facilities segment is projected to expand rapidly in the market in the coming years. The growing demand for minimally invasive surgeries increases the demand for outpatient facilities. Outpatient facilities reduce hospital stays and healthcare costs, improving patient compliance and medication adherence. This ultimately improves the quality of life of individuals.

Regional Insights

Implantable Medical Devices Market NA, EU, APAC, LA, MEA Share, 2024 (%)

Favorable Regulatory Frameworks Dominated North America

North America dominated the global market share by 44% in 2024. Favorable regulatory frameworks and technological advancements drive the market. The region has an advanced healthcare infrastructure providing state-of-the-art treatment to patients. The increasing number of surgeries due to the rising prevalence of chronic disorders potentiate implantable medical devices market growth. The increasing investments by government and private organizations to conduct research and manufacture implantable medical devices augment the market.

U.S. Market Trends

The presence of key players is a significant growth factor in the market. Key players such as Abbott Laboratories, GE Healthcare, and Johnson and Johnson hold a major share of the market. Food and Drug Administration regulates the approval of implantable medical devices in the U.S. According to the American Medical Association, around 10% of Americans will have a device implanted into their bodies during their lifetimes.

Canada Market Trends

Favorable government policies and increasing investments boost the market. The Canadian government focuses on improving the safety and effectiveness of medical devices and optimizing health outcomes for patients. The increasing number of hospitalizations propels the market. In 2023, there were more than 3.05 million hospitalizations in Canada, raising the demand for implantable devices.

Burgeoning Medical Device Sector Promote Asia-Pacific

Asia-Pacific is projected to host a significantly growing implantable medical devices market in the coming years. The rising geriatric population increases the risk of chronic disorders. The rapidly expanding medical device sector contributes to market growth. The rising healthcare expenditure encourages patients to use advanced implantable devices. Several government and private institutions conduct seminars and symposiums to raise awareness about novel implantable medical devices. The availability of suitable manufacturing infrastructure supports indigenous manufacturing of implantable devices.

China Market Trends

China’s National Medical Products Administration (NMPA) approved 117 novel medical devices in 2023. In August 2024, NMPA released the draft of China’s medical device law, “Medical Device Administration Law of the People’s Republic of China,” to underscore China’s commitment to enhancing the safety, effectiveness, and innovation of medical devices.

India Market Trends

The increasing investments and medical device startups augment market growth in India. There are about 885 medical device startups in India as of March 2025. The Indian government supports the indigenous manufacturing of medical devices through its “Make in India” policy. The government had launched the Production Linked Incentive (PLI), whose total financial outlay is Rs 3,420 crore, with production tenure from FY 2022- 23 to FY 2026- 27.

Rising Prevalence of Chronic Disorders to Drive Europe

Europe is considered to be a significantly growing area in the implantable medical devices market during the forecast period. The European Medicines Agency (EMA) regulates implantable medical devices in Europe. The rising prevalence of chronic disorders promotes the market. More than one-third of the European population, accounting for 35% of people, suffered from chronic disorders in 2023. The presence of key players such as Fresenius Medical Care, Medtronic, and Royal Philips fosters market growth.

Germany Market Trends

Germany is the third-largest medical technology market globally, after the U.S. and Japan. The growing research and development activities lead to the formation of novel implantable medical devices. The German government regulates implantable devices through the Medical Device Regulation (MDR) and the Medical Device Implementation Act (MPDG).

UK Market Trends

The increasing investments and rising healthcare expenditure favor the market. The Medtech sector in the UK represents over half of all life sciences employment and contributes billions of pounds to the economy. The UK government’s National Health Service (NHS) spends around 17% on implants and prostheses.

Top Companies in the Implantable Medical Devices Market

Implantable Medical Devices Market Companies

Latest Announcements by Industry Leaders

Arnaud Mascarell, CEO and Co-founder of FineHeart, commented on the successful filing of six new international patents for FlowMaker that these new patents consolidate the company’s position as a leading innovator in implantable medical devices. He also added that the technological innovations of FlowMaker underline their ongoing commitment to improving cardiac care for all patients worldwide.

Recent Developments in the Implantable Medical Devices Market

  • In June 2024, researchers from the Beijing Institute of Technology and Rutgers University launched a series of innovative electrospinning techniques to enhance the functionality and effectiveness of medical devices. This technology can revolutionize the development of nano/microrobots, wearable/implantable biosensors, and organ-on-chip systems.
  • In June 2024, Royal Philips announced the launch of an implantable medical device, Duo Venous Stent System, to treat symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI). The stent withstands the forces of compression and has the flexibility to accommodate the curvature of the vessel.

Segments Covered in the Report

By Product

  • Cardiovascular Implants
  • Dental Implants
  • Orthopedic Implants
  • Ophthalmology Implants
  • Aesthetic Implants
  • Neurology Implants

By Biomaterial

  • Metallic
  • Natural
  • Ceramic
  • Polymers

By End-Use

  • Hospitals
  • Outpatient Facilities
  • Specialty Clinics & Centers

By Region

  • North America
    • U.S.
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Thailand
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait

Meet the Team

Shivani Zoting is a healthcare market research expert with 2+ years of experience, specializing in analyzing trends, identifying growth opportunities, and providing actionable insights for businesses across healthcare sectors.

Learn more about Shivani Zoting

Aditi Shivarkar, with 14+ years of healthcare market research experience, ensures the accuracy, clarity, and relevance of reports. Her expertise helps businesses make informed decisions and stay competitive in healthcare sectors.

Learn more about Aditi Shivarkar

Related Reports

Implantable Medical Devices Market Climbs $176.33 Bn by 2034
FAQ's

The common examples of implantable medical devices are reconstructive joint replacements, cardiac pacemakers, defibrillators, stents, valves, tissue-engineered constructs, and drug delivery systems.

Implantable medical devices offer improved functionality, enhanced independence, and targeted therapy.

Food and Drug Administration, American Medical Association, Health Canada, Press Information Bureau, GOV.UK